APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biofermin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biofermin Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchBiofermin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Biofermin Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Biofermin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biofermin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Biofermin Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Biofermin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biofermin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biofermin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biofermin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biofermin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Biofermin include Shandong Baiwei Pharmaceutical, Sinoway Pharmaceutical, Taisho, Okobaike Biotechnology, Huibei Widely Chemical Technology, Hebei Tianyuan Pharmaceutical, Hebei Huanhai Pharmaceutical and Guilin Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biofermin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biofermin, also provides the sales of main regions and countries. Of the upcoming market potential for Biofermin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biofermin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biofermin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Biofermin sales, projected growth trends, production technology, application and end-user industry.

Biofermin Segment by Company

Shandong Baiwei Pharmaceutical

Sinoway Pharmaceutical

Taisho

Okobaike Biotechnology

Huibei Widely Chemical Technology

Hebei Tianyuan Pharmaceutical

Hebei Huanhai Pharmaceutical

Guilin Pharmaceutical

Biofermin Segment by Type

Tablets

Powdery

Other

Biofermin Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Biofermin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biofermin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biofermin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biofermin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Biofermin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Biofermin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biofermin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biofermin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Manufacturers Table 3. Powdery Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Biofermin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Retail Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Hospital Pharmacies Major Manufacturers Table 9. Biofermin Industry Trends Table 10. Biofermin Industry Drivers Table 11. Biofermin Industry Opportunities and Challenges Table 12. Biofermin Industry Restraints Table 13. Global Biofermin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Biofermin Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Biofermin Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Biofermin Revenue Market Share by Region (2021-2026) Table 17. Global Biofermin Revenue Market Share by Region (2027-2032) Table 18. Global Biofermin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 19. Global Biofermin Sales by Region (2021-2026) & (tons) Table 20. Global Biofermin Sales by Region (2027-2032) & (tons) Table 21. Global Biofermin Sales Market Share by Region (2021-2026) Table 22. Global Biofermin Sales Market Share by Region (2027-2032) Table 23. Global Biofermin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Biofermin Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Biofermin Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Biofermin Sales Market Share by Manufacturers (2021-2026) Table 27. Global Biofermin Sales Price (US$/kg) of Manufacturers (2021-2026) Table 28. Global Biofermin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Biofermin Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Biofermin Manufacturers, Product Type & Application Table 31. Global Biofermin Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Biofermin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Biofermin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Biofermin Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Biofermin Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Biofermin Revenue Market Share by Type (2021-2026) Table 38. Global Biofermin Revenue Market Share by Type (2027-2032) Table 39. Global Biofermin Sales by Type 2021 VS 2025 VS 2032 (tons) Table 40. Global Biofermin Sales by Type (2021-2026) & (tons) Table 41. Global Biofermin Sales by Type (2027-2032) & (tons) Table 42. Global Biofermin Sales Market Share by Type (2021-2026) Table 43. Global Biofermin Sales Market Share by Type (2027-2032) Table 44. Global Biofermin Price by Type (2021-2026) & (US$/kg) Table 45. Global Biofermin Price by Type (2027-2032) & (US$/kg) Table 46. Global Biofermin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Biofermin Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Biofermin Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Biofermin Revenue Market Share by Application (2021-2026) Table 50. Global Biofermin Revenue Market Share by Application (2027-2032) Table 51. Global Biofermin Sales by Application 2021 VS 2025 VS 2032 (tons) Table 52. Global Biofermin Sales by Application (2021-2026) & (tons) Table 53. Global Biofermin Sales by Application (2027-2032) & (tons) Table 54. Global Biofermin Sales Market Share by Application (2021-2026) Table 55. Global Biofermin Sales Market Share by Application (2027-2032) Table 56. Global Biofermin Price by Application (2021-2026) & (US$/kg) Table 57. Global Biofermin Price by Application (2027-2032) & (US$/kg) Table 58. Shandong Baiwei Pharmaceutical Company Information Table 59. Shandong Baiwei Pharmaceutical Business Overview Table 60. Shandong Baiwei Pharmaceutical Biofermin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 61. Shandong Baiwei Pharmaceutical Biofermin Product Portfolio Table 62. Shandong Baiwei Pharmaceutical Recent Development Table 63. Sinoway Pharmaceutical Company Information Table 64. Sinoway Pharmaceutical Business Overview Table 65. Sinoway Pharmaceutical Biofermin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. Sinoway Pharmaceutical Biofermin Product Portfolio Table 67. Sinoway Pharmaceutical Recent Development Table 68. Taisho Company Information Table 69. Taisho Business Overview Table 70. Taisho Biofermin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. Taisho Biofermin Product Portfolio Table 72. Taisho Recent Development Table 73. Okobaike Biotechnology Company Information Table 74. Okobaike Biotechnology Business Overview Table 75. Okobaike Biotechnology Biofermin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Okobaike Biotechnology Biofermin Product Portfolio Table 77. Okobaike Biotechnology Recent Development Table 78. Huibei Widely Chemical Technology Company Information Table 79. Huibei Widely Chemical Technology Business Overview Table 80. Huibei Widely Chemical Technology Biofermin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Huibei Widely Chemical Technology Biofermin Product Portfolio Table 82. Huibei Widely Chemical Technology Recent Development Table 83. Hebei Tianyuan Pharmaceutical Company Information Table 84. Hebei Tianyuan Pharmaceutical Business Overview Table 85. Hebei Tianyuan Pharmaceutical Biofermin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Hebei Tianyuan Pharmaceutical Biofermin Product Portfolio Table 87. Hebei Tianyuan Pharmaceutical Recent Development Table 88. Hebei Huanhai Pharmaceutical Company Information Table 89. Hebei Huanhai Pharmaceutical Business Overview Table 90. Hebei Huanhai Pharmaceutical Biofermin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. Hebei Huanhai Pharmaceutical Biofermin Product Portfolio Table 92. Hebei Huanhai Pharmaceutical Recent Development Table 93. Guilin Pharmaceutical Company Information Table 94. Guilin Pharmaceutical Business Overview Table 95. Guilin Pharmaceutical Biofermin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 96. Guilin Pharmaceutical Biofermin Product Portfolio Table 97. Guilin Pharmaceutical Recent Development Table 98. North America Biofermin Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Biofermin Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Biofermin Sales by Type (2021-2026) & (tons) Table 101. North America Biofermin Sales by Type (2027-2032) & (tons) Table 102. North America Biofermin Sales Price by Type (2021-2026) & (US$/kg) Table 103. North America Biofermin Sales Price by Type (2027-2032) & (US$/kg) Table 104. North America Biofermin Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Biofermin Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Biofermin Sales by Application (2021-2026) & (tons) Table 107. North America Biofermin Sales by Application (2027-2032) & (tons) Table 108. North America Biofermin Sales Price by Application (2021-2026) & (US$/kg) Table 109. North America Biofermin Sales Price by Application (2027-2032) & (US$/kg) Table 110. North America Biofermin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Biofermin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Biofermin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Biofermin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 114. North America Biofermin Sales by Country (2021-2026) & (tons) Table 115. North America Biofermin Sales by Country (2027-2032) & (tons) Table 116. North America Biofermin Sales Price by Country (2021-2026) & (US$/kg) Table 117. North America Biofermin Sales Price by Country (2027-2032) & (US$/kg) Table 118. United States Biofermin Revenue (2021-2032) & (US$ Million) Table 119. Canada Biofermin Revenue (2021-2032) & (US$ Million) Table 120. Mexico Biofermin Revenue (2021-2032) & (US$ Million) Table 121. Europe Biofermin Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Biofermin Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Biofermin Sales by Type (2021-2026) & (tons) Table 124. Europe Biofermin Sales by Type (2027-2032) & (tons) Table 125. Europe Biofermin Sales Price by Type (2021-2026) & (US$/kg) Table 126. Europe Biofermin Sales Price by Type (2027-2032) & (US$/kg) Table 127. Europe Biofermin Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Biofermin Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Biofermin Sales by Application (2021-2026) & (tons) Table 130. Europe Biofermin Sales by Application (2027-2032) & (tons) Table 131. Europe Biofermin Sales Price by Application (2021-2026) & (US$/kg) Table 132. Europe Biofermin Sales Price by Application (2027-2032) & (US$/kg) Table 133. Europe Biofermin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Biofermin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Biofermin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Biofermin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 137. Europe Biofermin Sales by Country (2021-2026) & (tons) Table 138. Europe Biofermin Sales by Country (2027-2032) & (tons) Table 139. Europe Biofermin Sales Price by Country (2021-2026) & (US$/kg) Table 140. Europe Biofermin Sales Price by Country (2027-2032) & (US$/kg) Table 141. Germany Biofermin Revenue (2021-2032) & (US$ Million) Table 142. France Biofermin Revenue (2021-2032) & (US$ Million) Table 143. U.K. Biofermin Revenue (2021-2032) & (US$ Million) Table 144. Italy Biofermin Revenue (2021-2032) & (US$ Million) Table 145. Russia Biofermin Revenue (2021-2032) & (US$ Million) Table 146. Spain Biofermin Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Biofermin Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Biofermin Revenue (2021-2032) & (US$ Million) Table 149. Sweden Biofermin Revenue (2021-2032) & (US$ Million) Table 150. Poland Biofermin Revenue (2021-2032) & (US$ Million) Table 151. China Biofermin Revenue by Type (2021-2026) & (US$ Million) Table 152. China Biofermin Revenue by Type (2027-2032) & (US$ Million) Table 153. China Biofermin Sales by Type (2021-2026) & (tons) Table 154. China Biofermin Sales by Type (2027-2032) & (tons) Table 155. China Biofermin Sales Price by Type (2021-2026) & (US$/kg) Table 156. China Biofermin Sales Price by Type (2027-2032) & (US$/kg) Table 157. China Biofermin Revenue by Application (2021-2026) & (US$ Million) Table 158. China Biofermin Revenue by Application (2027-2032) & (US$ Million) Table 159. China Biofermin Sales by Application (2021-2026) & (tons) Table 160. China Biofermin Sales by Application (2027-2032) & (tons) Table 161. China Biofermin Sales Price by Application (2021-2026) & (US$/kg) Table 162. China Biofermin Sales Price by Application (2027-2032) & (US$/kg) Table 163. Asia Biofermin Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Biofermin Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Biofermin Sales by Type (2021-2026) & (tons) Table 166. Asia Biofermin Sales by Type (2027-2032) & (tons) Table 167. Asia Biofermin Sales Price by Type (2021-2026) & (US$/kg) Table 168. Asia Biofermin Sales Price by Type (2027-2032) & (US$/kg) Table 169. Asia Biofermin Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Biofermin Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Biofermin Sales by Application (2021-2026) & (tons) Table 172. Asia Biofermin Sales by Application (2027-2032) & (tons) Table 173. Asia Biofermin Sales Price by Application (2021-2026) & (US$/kg) Table 174. Asia Biofermin Sales Price by Application (2027-2032) & (US$/kg) Table 175. Asia Biofermin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Biofermin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Biofermin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Biofermin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 179. Asia Biofermin Sales by Country (2021-2026) & (tons) Table 180. Asia Biofermin Sales by Country (2027-2032) & (tons) Table 181. Asia Biofermin Sales Price by Country (2021-2026) & (US$/kg) Table 182. Asia Biofermin Sales Price by Country (2027-2032) & (US$/kg) Table 183. Japan Biofermin Revenue (2021-2032) & (US$ Million) Table 184. South Korea Biofermin Revenue (2021-2032) & (US$ Million) Table 185. India Biofermin Revenue (2021-2032) & (US$ Million) Table 186. Australia Biofermin Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Biofermin Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Biofermin Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Biofermin Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Biofermin Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Biofermin Sales by Type (2021-2026) & (tons) Table 192. SAMEA Biofermin Sales by Type (2027-2032) & (tons) Table 193. SAMEA Biofermin Sales Price by Type (2021-2026) & (US$/kg) Table 194. SAMEA Biofermin Sales Price by Type (2027-2032) & (US$/kg) Table 195. SAMEA Biofermin Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Biofermin Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Biofermin Sales by Application (2021-2026) & (tons) Table 198. SAMEA Biofermin Sales by Application (2027-2032) & (tons) Table 199. SAMEA Biofermin Sales Price by Application (2021-2026) & (US$/kg) Table 200. SAMEA Biofermin Sales Price by Application (2027-2032) & (US$/kg) Table 201. SAMEA Biofermin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Biofermin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Biofermin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Biofermin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 205. SAMEA Biofermin Sales by Country (2021-2026) & (tons) Table 206. SAMEA Biofermin Sales by Country (2027-2032) & (tons) Table 207. SAMEA Biofermin Sales Price by Country (2021-2026) & (US$/kg) Table 208. SAMEA Biofermin Sales Price by Country (2027-2032) & (US$/kg) Table 209. Brazil Biofermin Revenue (2021-2032) & (US$ Million) Table 210. Argentina Biofermin Revenue (2021-2032) & (US$ Million) Table 211. Chile Biofermin Revenue (2021-2032) & (US$ Million) Table 212. Colombia Biofermin Revenue (2021-2032) & (US$ Million) Table 213. Peru Biofermin Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Biofermin Revenue (2021-2032) & (US$ Million) Table 215. Israel Biofermin Revenue (2021-2032) & (US$ Million) Table 216. UAE Biofermin Revenue (2021-2032) & (US$ Million) Table 217. Turkey Biofermin Revenue (2021-2032) & (US$ Million) Table 218. Iran Biofermin Revenue (2021-2032) & (US$ Million) Table 219. Egypt Biofermin Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Biofermin Distributors List Table 223. Biofermin Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Biofermin Image Figure 2. Global Biofermin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biofermin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Powdery Image Figure 6. Other Image Figure 7. Global Biofermin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Biofermin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Retail Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Hospital Pharmacies Image Figure 12. Global Biofermin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Biofermin Revenue (2021-2032) & (US$ Million) Figure 14. Global Biofermin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Biofermin Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Biofermin Revenue Market Share by Region (2021-2032) Figure 17. Global Biofermin Sales (2021-2032) & (tons) Figure 18. Global Biofermin Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 19. Global Biofermin Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Biofermin Sales YoY (2021-2032) & (tons) Figure 21. Europe Biofermin Sales YoY (2021-2032) & (tons) Figure 22. China Biofermin Sales YoY (2021-2032) & (tons) Figure 23. Asia (Excluding China) Biofermin Sales YoY (2021-2032) & (tons) Figure 24. South America, Middle East and Africa Biofermin Sales YoY (2021-2032) & (tons) Figure 25. Global Biofermin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Biofermin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Biofermin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Biofermin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Biofermin Revenue Market Share by Type (2021-2032) Figure 31. Global Biofermin Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 32. Global Biofermin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Biofermin Sales Market Share by Type (2021-2032) Figure 34. Global Biofermin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Biofermin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Biofermin Revenue Market Share by Application (2021-2032) Figure 37. Global Biofermin Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 38. Global Biofermin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Biofermin Sales Market Share by Application (2021-2032) Figure 40. North America Biofermin Revenue Share by Type (2021-2032) Figure 41. North America Biofermin Sales Share by Type (2021-2032) Figure 42. North America Biofermin Revenue Share by Application (2021-2032) Figure 43. North America Biofermin Sales Share by Application (2021-2032) Figure 44. North America Biofermin Revenue Share by Country (2021-2032) Figure 45. North America Biofermin Sales Share by Country (2021-2032) Figure 46. Europe Biofermin Revenue Share by Type (2021-2032) Figure 47. Europe Biofermin Sales Share by Type (2021-2032) Figure 48. Europe Biofermin Revenue Share by Application (2021-2032) Figure 49. Europe Biofermin Sales Share by Application (2021-2032) Figure 50. Europe Biofermin Revenue Share by Country (2021-2032) Figure 51. Europe Biofermin Sales Share by Country (2021-2032) Figure 52. China Biofermin Revenue Share by Type (2021-2032) Figure 53. China Biofermin Sales Share by Type (2021-2032) Figure 54. China Biofermin Revenue Share by Application (2021-2032) Figure 55. China Biofermin Sales Share by Application (2021-2032) Figure 56. Asia Biofermin Revenue Share by Type (2021-2032) Figure 57. Asia Biofermin Sales Share by Type (2021-2032) Figure 58. Asia Biofermin Revenue Share by Application (2021-2032) Figure 59. Asia Biofermin Sales Share by Application (2021-2032) Figure 60. Asia Biofermin Revenue Share by Country (2021-2032) Figure 61. Asia Biofermin Sales Share by Country (2021-2032) Figure 62. SAMEA Biofermin Revenue Share by Type (2021-2032) Figure 63. SAMEA Biofermin Sales Share by Type (2021-2032) Figure 64. SAMEA Biofermin Revenue Share by Application (2021-2032) Figure 65. SAMEA Biofermin Sales Share by Application (2021-2032) Figure 66. SAMEA Biofermin Revenue Share by Country (2021-2032) Figure 67. SAMEA Biofermin Sales Share by Country (2021-2032) Figure 68. Biofermin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Biofermin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Powdery
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Shandong Baiwei Pharmaceutical
  • Sinoway Pharmaceutical
  • Taisho
  • Okobaike Biotechnology
  • Huibei Widely Chemical Technology
  • Hebei Tianyuan Pharmaceutical
  • Hebei Huanhai Pharmaceutical
  • Guilin Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biofermin Market by Type
  3. 1.2.1 Global Biofermin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Powdery
  6. 1.2.4 Other
  7. 1.3 Biofermin Market by Application
  8. 1.3.1 Global Biofermin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Hospital Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Biofermin Market Dynamics
  1. 2.1 Biofermin Industry Trends
  2. 2.2 Biofermin Industry Drivers
  3. 2.3 Biofermin Industry Opportunities and Challenges
  4. 2.4 Biofermin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Biofermin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Biofermin Revenue by Region
  3. 3.2.1 Global Biofermin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biofermin Revenue by Region (2021-2026)
  5. 3.2.3 Global Biofermin Revenue by Region (2027-2032)
  6. 3.2.4 Global Biofermin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Biofermin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Biofermin Sales by Region
  9. 3.4.1 Global Biofermin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Biofermin Sales by Region (2021-2026)
  11. 3.4.3 Global Biofermin Sales by Region (2027-2032)
  12. 3.4.4 Global Biofermin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Biofermin Revenue by Manufacturers
  2. 4.1.1 Global Biofermin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Biofermin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Biofermin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biofermin Sales by Manufacturers
  6. 4.2.1 Global Biofermin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Biofermin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Biofermin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Biofermin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Biofermin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Biofermin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Biofermin Manufacturers, Product Type & Application
  13. 4.7 Global Biofermin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Biofermin Market CR5 and HHI
  16. 4.8.2 2025 Biofermin Tier 1, Tier 2, and Tier 3
5 Biofermin Market by Type
  1. 5.1 Global Biofermin Revenue by Type
  2. 5.1.1 Global Biofermin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Biofermin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Biofermin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Biofermin Sales by Type
  6. 5.2.1 Global Biofermin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biofermin Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Biofermin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Biofermin Price by Type
6 Biofermin Market by Application
  1. 6.1 Global Biofermin Revenue by Application
  2. 6.1.1 Global Biofermin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Biofermin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Biofermin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Biofermin Sales by Application
  6. 6.2.1 Global Biofermin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Biofermin Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Biofermin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Biofermin Price by Application
7 Company Profiles
  1. 7.1 Shandong Baiwei Pharmaceutical
  2. 7.1.1 Shandong Baiwei Pharmaceutical Company Information
  3. 7.1.2 Shandong Baiwei Pharmaceutical Business Overview
  4. 7.1.3 Shandong Baiwei Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shandong Baiwei Pharmaceutical Biofermin Product Portfolio
  6. 7.1.5 Shandong Baiwei Pharmaceutical Recent Developments
  7. 7.2 Sinoway Pharmaceutical
  8. 7.2.1 Sinoway Pharmaceutical Company Information
  9. 7.2.2 Sinoway Pharmaceutical Business Overview
  10. 7.2.3 Sinoway Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sinoway Pharmaceutical Biofermin Product Portfolio
  12. 7.2.5 Sinoway Pharmaceutical Recent Developments
  13. 7.3 Taisho
  14. 7.3.1 Taisho Company Information
  15. 7.3.2 Taisho Business Overview
  16. 7.3.3 Taisho Biofermin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Taisho Biofermin Product Portfolio
  18. 7.3.5 Taisho Recent Developments
  19. 7.4 Okobaike Biotechnology
  20. 7.4.1 Okobaike Biotechnology Company Information
  21. 7.4.2 Okobaike Biotechnology Business Overview
  22. 7.4.3 Okobaike Biotechnology Biofermin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Okobaike Biotechnology Biofermin Product Portfolio
  24. 7.4.5 Okobaike Biotechnology Recent Developments
  25. 7.5 Huibei Widely Chemical Technology
  26. 7.5.1 Huibei Widely Chemical Technology Company Information
  27. 7.5.2 Huibei Widely Chemical Technology Business Overview
  28. 7.5.3 Huibei Widely Chemical Technology Biofermin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Huibei Widely Chemical Technology Biofermin Product Portfolio
  30. 7.5.5 Huibei Widely Chemical Technology Recent Developments
  31. 7.6 Hebei Tianyuan Pharmaceutical
  32. 7.6.1 Hebei Tianyuan Pharmaceutical Company Information
  33. 7.6.2 Hebei Tianyuan Pharmaceutical Business Overview
  34. 7.6.3 Hebei Tianyuan Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hebei Tianyuan Pharmaceutical Biofermin Product Portfolio
  36. 7.6.5 Hebei Tianyuan Pharmaceutical Recent Developments
  37. 7.7 Hebei Huanhai Pharmaceutical
  38. 7.7.1 Hebei Huanhai Pharmaceutical Company Information
  39. 7.7.2 Hebei Huanhai Pharmaceutical Business Overview
  40. 7.7.3 Hebei Huanhai Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hebei Huanhai Pharmaceutical Biofermin Product Portfolio
  42. 7.7.5 Hebei Huanhai Pharmaceutical Recent Developments
  43. 7.8 Guilin Pharmaceutical
  44. 7.8.1 Guilin Pharmaceutical Company Information
  45. 7.8.2 Guilin Pharmaceutical Business Overview
  46. 7.8.3 Guilin Pharmaceutical Biofermin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Guilin Pharmaceutical Biofermin Product Portfolio
  48. 7.8.5 Guilin Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Biofermin Market Size by Type
  2. 8.1.1 North America Biofermin Revenue by Type (2021-2032)
  3. 8.1.2 North America Biofermin Sales by Type (2021-2032)
  4. 8.1.3 North America Biofermin Price by Type (2021-2032)
  5. 8.2 North America Biofermin Market Size by Application
  6. 8.2.1 North America Biofermin Revenue by Application (2021-2032)
  7. 8.2.2 North America Biofermin Sales by Application (2021-2032)
  8. 8.2.3 North America Biofermin Price by Application (2021-2032)
  9. 8.3 North America Biofermin Market Size by Country
  10. 8.3.1 North America Biofermin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Biofermin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Biofermin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Biofermin Market Size by Type
  2. 9.1.1 Europe Biofermin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Biofermin Sales by Type (2021-2032)
  4. 9.1.3 Europe Biofermin Price by Type (2021-2032)
  5. 9.2 Europe Biofermin Market Size by Application
  6. 9.2.1 Europe Biofermin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Biofermin Sales by Application (2021-2032)
  8. 9.2.3 Europe Biofermin Price by Application (2021-2032)
  9. 9.3 Europe Biofermin Market Size by Country
  10. 9.3.1 Europe Biofermin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Biofermin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Biofermin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Biofermin Market Size by Type
  2. 10.1.1 China Biofermin Revenue by Type (2021-2032)
  3. 10.1.2 China Biofermin Sales by Type (2021-2032)
  4. 10.1.3 China Biofermin Price by Type (2021-2032)
  5. 10.2 China Biofermin Market Size by Application
  6. 10.2.1 China Biofermin Revenue by Application (2021-2032)
  7. 10.2.2 China Biofermin Sales by Application (2021-2032)
  8. 10.2.3 China Biofermin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biofermin Market Size by Type
  2. 11.1.1 Asia Biofermin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Biofermin Sales by Type (2021-2032)
  4. 11.1.3 Asia Biofermin Price by Type (2021-2032)
  5. 11.2 Asia Biofermin Market Size by Application
  6. 11.2.1 Asia Biofermin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Biofermin Sales by Application (2021-2032)
  8. 11.2.3 Asia Biofermin Price by Application (2021-2032)
  9. 11.3 Asia Biofermin Market Size by Country
  10. 11.3.1 Asia Biofermin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Biofermin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Biofermin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biofermin Market Size by Type
  2. 12.1.1 SAMEA Biofermin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Biofermin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Biofermin Price by Type (2021-2032)
  5. 12.2 SAMEA Biofermin Market Size by Application
  6. 12.2.1 SAMEA Biofermin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Biofermin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Biofermin Price by Application (2021-2032)
  9. 12.3 SAMEA Biofermin Market Size by Country
  10. 12.3.1 SAMEA Biofermin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Biofermin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Biofermin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Biofermin Value Chain Analysis
  2. 13.1.1 Biofermin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Biofermin Production Mode & Process
  6. 13.2 Biofermin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Biofermin Distributors
  9. 13.2.3 Biofermin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst